Press Releases
Jan. 29, 2026
USD496M Spent on Trump's National Guard Deployments
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
7 hours ago
Edible Garden’s Gourmet Greens Hydroponic Basil Now Available at Hannaford
Indeterminate
GlobeNewswire, Inc.
8 hours ago
Edible Garden Announces Reverse Stock Split of the Company’s Common Stock
Indeterminate
GlobeNewswire, Inc.
11 hours ago
Solid Board for Food Packaging Market Companies Statistics 2026
Indeterminate
GlobeNewswire, Inc.
Jan. 29, 2026
U.S. Ambulatory Surgery Center Market Size to Hit USD 80.60 Billion by 2035
Indeterminate
GlobeNewswire, Inc.
Jan. 29, 2026
Maine DACF Deputy Commissioner Shares State's PFAS Response at Congressional Briefing
Gov't Institution
State of Maine Agencies
Owner: American Government
Jan. 29, 2026
Maine DACF Deputy Commissioner Shares State's PFAS Response at Congressional Briefing
Gov't Institution
Maine Government
Owner: American Government
Jan. 29, 2026
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Indeterminate
GlobeNewswire, Inc.
Jan. 29, 2026
Martinique’s Muriel Wiltord Champions Caribbean Unity at New York Travel Show
Neutral
EIN Presswire
Jan. 29, 2026
Survey Data Shows Americans’ Willingness to Trade Comfort for Longer Health
Neutral
EIN Presswire
Jan. 29, 2026
Glucosamine Supplement for Joints: A NUTRAHARMONY Buyer’s Guide (Glucosamine + Chondroitin + Collagen)
Indeterminate
GlobeNewswire, Inc.
Jan. 29, 2026
Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Largest Charcuterie Manufacturer in the U.S., Charcuterie Artisans, Opens Innovation Center, Expands Capacity
Neutral
EIN Presswire
2 hours ago
Muddy Water Adventures Debuts Cruise‑friendly Regional Itinerary Design For Bear Viewing in Alaska
Neutral
EIN Presswire
Jan. 28, 2026
U.S. Consumer Confidence Tumbles to Lowest Level in Over Ten Years
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 28, 2026
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Butchertown Clinical Trials Celebrates Milestone 25th FDA Approval
Neutral
EIN Presswire